Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FV104
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,827
Award facts
- Contract value 100% obligated
- $28,827.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,827.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens. This non-set-aside competitive award was issued on December 30, 2025, with an ultimate completion date of December 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical devices. The company's federal contract awards with the Defense Logistics Agency and Defense Health Agency demonstrate its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains in open competition. Cosentyx, a biologic immunosuppressant used primarily for autoimmune conditions, represents one of many specialty medications supplied under the company's prime vendor agreements supporting U.S. military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FV104?
SPE2DR26FV104 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FV104 worth?
The government has obligated $28,827 on SPE2DR26FV104.
Is contract SPE2DR26FV104 an order under another contract?
Yes. SPE2DR26FV104 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV104 competed?
The extent of competition for SPE2DR26FV104 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award